期刊文献+

连续性肾脏替代治疗呼吸衰竭合并急性肾功能衰竭的效果观察 被引量:3

下载PDF
导出
摘要 目的观察连续性肾脏替代治疗呼吸衰竭合并急性肾功能衰竭的临床效果。方法选择2016年1月-2018年12月辽宁省抚顺市职业病防治院收治的呼吸衰竭合并急性肾功能衰竭患者50例,按治疗方式不同分为连续性组和间歇组,每组25例。间歇组采取间歇性肾脏替代治疗,连续性组则采取连续性肾脏替代治疗。比较2组临床疗效,治疗前后血尿素氮、血肌酐、动脉血氧分压水平、呼吸频率,呼吸衰竭纠正时间及肾功能好转时间,代谢紊乱发生率。结果连续性组总有效率为100.00%,高于间歇组的80.00%(P<0.05);治疗后,2组血尿素氮、血肌酐水平及呼吸频率均低于治疗前,动脉血氧分压水平高于治疗前,且连续性组优于间歇组(P<0.05);连续性组呼吸衰竭纠正时间及肾功能好转时间均短于间歇组(P<0.05);连续性组代谢紊乱发生率为4.00%,低于间歇组的20.00%(P<0.05)。结论连续性肾脏替代治疗呼吸衰竭合并急性肾功能衰竭的效果较好,值得临床推广应用。
作者 于洋
出处 《临床合理用药杂志》 2020年第5期131-132,共2页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献2

二级参考文献18

  • 1Hofmann U, Frantz S. Immunity strikes: heart failure as a systemic disease [J]. Eur Heart J, 2014,35(6) : 341-343. 被引量:1
  • 2Wing MR, Yang W, Teal V, Navaneethan S, et al. Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: Findings from the chronic renal insufficiency cohort study [J]. Obesity (Silver Spring), 2014, 11(1):1002. 被引量:1
  • 3Aroor A, McKarns S, Nistala R, et al. DPP-4 Inhibitors as therapeutic modulators of immune cell function and associated cardiovascular and renal insulin resistance in obesity and diabetes [ J ]. Cardiorenal Med, 2013,3 ( 1 ) : 48-56. 被引量:1
  • 4Wald R, Shariff SZ, Adhikari NK, et al. The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: A retrospective cohort study [J]. Crit Care Med, 2013,42(4): 838-877. 被引量:1
  • 5Giglioli C, Spini V, Landi D, et al. Congestive heart failure and deeongestion ability of two different treatments : continuous renal replacement and diuretie therapy: experience of a cardiac step down unit [J]. Aeta Cardiol, 2013,68 (4) : 355-364. 被引量:1
  • 6Murugaiyan G, Mittal A, Lopez-Diego R, et al. IL-27 is a key regulator of IL-10 and IL-17 production by humen CD4+ T ceils [ J ]. J hnmunol, 2009,183 (4) : 2435-2443. 被引量:1
  • 7Zhou Q, Zhao C, Xie D, et al. Acute and acute-on-chronic kidney injury of patients with decompensated heart failure:impact on outcomes [J]. BMC Nephrol, 2012,13(7):51. 被引量:1
  • 8McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC [J]. Eur Heart J, 2012,33(14) : 1787-1847. 被引量:1
  • 9Leo K, Gabriel Y, Pui-Wai L. Comparison of angiotensin- converting enzyme inhibitor alone and in combination with irbesartan for the treatment of heart failure [J]. International Journal of Cardiology, 2008,125 : 16-21. 被引量:1
  • 10Bart BA, Goldsmith SR, Lee KL, et al. Heart Failure Clinical Research Network.Uhrafiltration in deeompensated heart failure with eardiorenal syndrome [ J 1. N Engl J Med, 2012,367 (24) : 2296-2304. 被引量:1

共引文献25

同被引文献41

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部